Disruption of plasmepsin-4 and merozoites surface protein-7 genes in Plasmodium berghei induces combined virulence-attenuated phenotype

Scientific Reports

Volumn 1, Issue , 2011, Pages

  Spaccapelo, Roberta ^a   Aime, Elena ^a   Caterbi, Sara ^a   Arcidiacono, Paola ^a   Capuccini, Barbara ^a   Di Cristina, Manlio ^a   Dottorini, Tania ^a   Rende, Mario ^a   Bistoni, Francesco ^a   Crisanti, Andrea ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; MEMBRANE PROTEIN; MEROZOITE SURFACE PROTEIN 7, PLASMODIUM; PLASMEPSIN; PROTOZOAL PROTEIN; VIRULENCE FACTOR;

ANIMAL; ARTICLE; C57BL MOUSE; DISEASE MODEL; GENE SILENCING; GENETICS; MALARIA; METABOLISM; MOUSE; PARASITOLOGY; PATHOGENICITY; PLASMODIUM BERGHEI; SURVIVAL RATE;

ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; GENE SILENCING; MALARIA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS; SURVIVAL RATE; VIRULENCE FACTORS;

EID: 84860208469     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00039     Document Type: Article

References (60)

1. Grau, G. E., Piguet, P. F., Vassalli, P. & Lambert, P. H. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev. 112, 49-70 (1989). (Pubitemid 20048807)
2. Engwerda, C., Belnoue, E., Gruner, A. C. & Renia, L. Experimental models of cerebral malaria. Curr Top Microbiol Immunol. 297, 103-43 (2005). (Pubitemid 41383379)
3. van der Heyde, H. C., Nolan, J., Combes, V., Gramaglia, I. & Grau, G. E. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22, 503-8 (2006). (Pubitemid 44479847)
4. Sein, K. K., Maeno, Y., Thuc, H. V., Anh, T. K. & Aikawa, M. Differential sequestration of parasitized erythrocytes in the cerebrum and cerebellum in human cerebral malaria. Am J Trop Med Hyg. 48, 504-11 (1993). (Pubitemid 23141285)
5. Brabin, B. J. et al. The sick placenta-the role of malaria. Placenta. 25, 359-78 (2004).
6. Schofield, L. Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunol Cell Biol. 85, 130-7 (2007). (Pubitemid 46398731)
7. Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F. & Taylor, D. W. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis 7, 105-17 (2007). (Pubitemid 46123133)
8. Nunes, M. C. & Scherf, A. Plasmodium falciparum during pregnancy: a puzzling parasite tissue adhesion tropism. Parasitology. 134, 1863-9 (2007). (Pubitemid 350014549)
9. Newbold, C. I. et al. PfEMP1, polymorphism and pathogenesis. Ann Trop Med Parasitol. 91, 551-7 (1997). (Pubitemid 27367592)
10. Kraemer, S. M. & Smith, J. D. A family affair: var genes, PfEMP1 binding, and malaria disease. Curr Opin Microbiol. 9, 374-80 (2006). (Pubitemid 44108717)
11. Fairhurst, R. M. & Wellems, T. E. Modulation of malaria virulence by determinants of Plasmodium falciparum erythrocyte membrane protein-1 display. Curr Opin Hematol 13, 124-30 (2006).
12. Gardiner, D. L., Skinner-Adams, T. S., Spielmann, T. & Trenholme, K. R. Malaria transfection and transfection vectors. Trends Parasitol. 19, 381-3 (2003). (Pubitemid 37101048)
13. Balu, B. & Adams, J. H. Functional genomics of Plasmodium falciparum through transposon-mediated mutagenesis. Cell Microbiol 8, 1529-36 (2006). (Pubitemid 44350012)
14. Balu, B. & Adams, J. H. Advancements in transfection technologies for Plasmodium. Int J Parasitol 37, 1-10 (2007). (Pubitemid 44958564)
15. Garcia, C. R. et al. Plasmodium in the postgenomic era: new insights into the molecular cell biology of malaria parasites. Int Rev Cell Mol Biol. 266, 85-156 (2008).
16. Baldi, D. L. et al. RAP1 controls rhoptry targeting of RAP2 in the malaria parasite Plasmodium falciparum. Embo J 19, 2435-43 (2000). (Pubitemid 30323533)
17. Triglia, T. et al. Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Mol Microbiol 38, 706-18 (2000).
18. Baldi, D. L., Good, R., Duraisingh, M. T., Crabb, B. S. & Cowman, A. F. Identification and disruption of the gene encoding the third member of the lowmolecular-mass rhoptry complex in Plasmodium falciparum. Infect Immun 70, 5236-45 (2002).
19. Miller, S. K. et al. A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle. J Biol Chem 277, 47524-32 (2002). (Pubitemid 36159271)
20. Klemba, M., Gluzman, I. & Goldberg, D. E. A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation. J Biol Chem 279, 43000-7 (2004). (Pubitemid 39372193)
21. Black, C. G., Wu, T., Wang, L., Topolska, A. E. & Coppel, R. L. MSP8 is a nonessential merozoite surface protein in Plasmodium falciparum. Mol Biochem Parasitol 144, 27-35 (2005). (Pubitemid 41393367)
22. Janse, C. J. et al. Malaria parasites lacking eef1a have a normal S/M phase yet grow more slowly due to a longer G1 phase. Mol Microbiol. 50, 1539-51 (2003). (Pubitemid 38010451)
23. Tewari, R., Ogun, S. A., Gunaratne, R. S., Crisanti, A. & Holder, A. A. Disruption of Plasmodium berghei merozoite surface protein 7 gene modulates parasite growth in vivo. Blood. 105, 394-6 (2005). (Pubitemid 40053110)
24. Thompson, J. et al. Plasmodium cysteine repeat modular proteins 1-4: complex proteins with roles throughout the malaria parasite life cycle. Cell Microbiol. 9, 1466-80 (2007). (Pubitemid 46774018)
25. de Koning-Ward, T. F., Drew, D. R., Chesson, J. M., Beeson, J. G. & Crabb, B. S. Truncation of Plasmodium berghei merozoite surface protein 8 does not affect in vivo blood-stage development. Mol Biochem Parasitol 159, 69-72 (2008). (Pubitemid 351469921)
26. Bonilla, J. A. et al. Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum. Int J Parasitol. 37, 317-27 (2007). (Pubitemid 46215589)
27. Kadekoppala, M., O'Donnell, R. A., Grainger, M., Crabb, B. S. & Holder, A. A. Deletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytes. Eukaryot Cell. 7, 2123-32 (2008).
28. Spaccapelo, R. et al. Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria. Am J Pathol 176, 205-17 (2010).
29. Mello, K. et al. A multigene family that interacts with the amino terminus of Plasmodium MSP-1 identified using the yeast two-hybrid system. Eukaryot Cell. 1, 915-25 (2002). (Pubitemid 36557712)
30. Kadekoppala, M., Ogun, S. A., Howell, S., Gunaratne, R. S. & Holder, A. A. Systematic genetic analysis of the Plasmodium falciparum MSP7-like family reveals differences in protein expression, location, and importance in asexual growth of the blood-stage parasite. Eukaryot Cell 9, 1064-74 (2010).
31. Franke-Fayard, B. et al. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci USA. 102, 11468-73 (2005). (Pubitemid 41153843)
32. Stevenson, M. M. & Riley, E. M. Innate immunity to malaria. Nat Rev Immunol. 4, 169-80 (2004). (Pubitemid 38339083)
33. Urban, B. C., Ing, R. & Stevenson, M. M. Early interactions between blood-stage plasmodium parasites and the immune system. Curr TopMicrobiol Immunol. 297, 25-70 (2005). (Pubitemid 41383377)
34. Langhorne, J., Ndungu, F. M., Sponaas, A. M. & Marsh, K. Immunity to malaria: more questions than answers. Nat Immunol. 9, 725-32 (2008). (Pubitemid 351859155)
35. Stephens, R. & Langhorne, J. Priming of CD41T cells and development of CD41 T cell memory; lessons for malaria. Parasite Immunol. 28, 25-30 (2006).
36. Curfs, J. H., van der Meide, P. H., Billiau, A., Meuwissen, J. H. & Eling, W. M. Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp Parasitol. 77, 212-23 (1993). (Pubitemid 23279549)
37. Hunt, N. H. & Grau, G. E. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24, 491-9 (2003). (Pubitemid 37088152)
38. Franke-Fayard, B., Waters, A. P. & Janse, C. J. Real-time in vivo imaging of transgenic bioluminescent blood stages of rodent malaria parasites in mice. Nat Protoc. 1, 476-85 (2006).
39. Pamplona, A. et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med. 13, 703-10 (2007). (Pubitemid 46889755)
40. Ting, L. M., Gissot, M., Coppi, A., Sinnis, P. & Kim, K. Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. Nat Med. 14, 954-8 (2008).
41. Aly, A. S., Downie, M. J., Mamoun, C. B. & Kappe, S. H. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice. Cell 12, 930-8 (2010).
42. Legorreta-Herrera, M., Ventura-Ayala, M. L., Licona-Chavez, R. N., Soto-Cruz, I. & Hernandez-Clemente, F. F. Early treatment during a primary malaria infection modifies the development of cross immunity. Parasite Immunol. 26, 7-17 (2004). (Pubitemid 38823980)
43. Elliott, S. R., Kuns, R. D. & Good, M. F. Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria. Infect Immun. 73, 2478-85 (2005). (Pubitemid 40470851)
44. Belnoue, E. et al. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol. 181, 8552-8 (2008).
45. Pombo, D. J. et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet. 360, 610-7 (2002). (Pubitemid 35232195)
46. Roestenberg, M. et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med. 361, 468-77 (2009).
47. Amante, F. H. et al. A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am J Pathol. 171, 548-59 (2007). (Pubitemid 47344687)
48. Nie, C. Q. et al. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 5, e1000369 (2009).
49. McCarthy, J. S. & Good, M. F. Whole parasite blood stage malaria vaccines: a convergence of evidence. Hum 6, 114-23 (2010).
50. Luke, T. C. & Hoffman, S. L. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol. 206, 3803-8 (2003). (Pubitemid 37365462)
51. Matuschewski, K. Vaccine development against malaria. Curr Opin Immunol. 18, 449-57 (2006). (Pubitemid 43947579)
52. Mikolajczak, S. A., Aly, A. S. & Kappe, S. H. Preerythrocytic malaria vaccine development. Curr Opin Infect Dis. 20, 461-6. (2007). (Pubitemid 47359641)
53. Renia, L., Gruner, A. C., Mauduit, M. & Snounou, G. Vaccination against malaria with live parasites. Expert Rev Vaccines. 5, 473-81 (2006). (Pubitemid 44627879)
54. Vaughan, A. M., Wang, R. & Kappe, S. H. Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum 6, 107-13 (2010).
55. Purcell, L. A., Yanow, S. K., Lee, M., Spithill, T. W. & Rodriguez, A. Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice. Infect Immun. 76, 1193-9 (2008). (Pubitemid 351428081)
56. Ishino, T., Chinzei, Y. & Yuda, M. Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte. Mol Microbiol. 58, 1264-75 (2005). (Pubitemid 41705408)
57. van Dijk, M. R. et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci USA. 102, 12194-9 (2005). (Pubitemid 41291151)
58. Labaied, M. et al. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun. 75, 3758-68 (2007). (Pubitemid 47206273)
59. Janse, C. J., Ramesar, J. & Waters, A. P. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat Protoc. 1, 346-56 (2006).
60. Benchenane, K. et al. Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRPindependent process. Stroke. 36, 1065-70 (2005).